Here, Kaplan–Meier analysis showed that the CD8+T cell enriched/ CSGALNACT2high group was associated with worse prognosis of ovarian cancer patients, compared with the CD8+T cell enriched/ CSGALNACT2low group (HR = 2.98, P = 0.0006). This evidence concerns the gene CD8A and ovarian cancer.